Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome
DOI:
https://doi.org/10.23938/ASSN.0635Keywords:
Cannabinoid hyperemesis syndrome. Pneumomediastinum. Cannabis. Capsaicin.Abstract
Cannabinoid hyperemesis syndrome (CHS) is characterised by abdominal pain and cyclical vomiting, after intense consumption of cannabis over years. It does not respond to treatment with antiemetics, but to showers in very hot water.
We present the case of a 24-year-old patient with cannabis consumption for 10 years and an episode of spontaneous idiopathic pneumomediastinum (PM) the previous month, which presented an association of CHS with the PM secondary to ntense, repeated vomiting. He was given topical capsaicin and 5 mg of intravenous haloperidol, and was kept for 48 hours in the Emergency Short Stay Unit.
This isolated clinical observation appears to indicate the need to rule out CHS as the cause of PM in young patients and, similarly, to consider the presence of PM in the clinical exploration of young people with CHS and in patients with pathologies whose aetiology might be influenced by an increase in intrathoracic pressure.
Downloads
References
ALLEN JH, DE MOORE GM, HEDDLE R, TWARTZ JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004; 53: 1566-1570. https://doi.org/10.1136/gut.2003.036350
SIMONETTO DA, OXENTENKO AS, HERMAN ML, SZOSTEK JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc 2012; 87: 114-119. https://doi.org/10.1016/j.mayocp.2011.10.005
LEE C, GREENE SL, WONG A. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome. Clin Toxicol 2019; 58: 1-5. https://doi.org/10.1080/15563650.2018.1564324
BURILLO-PUTZE G, LLORENS P. Perspectivas en el tratamiento del síndrome de hyperemesis por cannabis. Adicciones 2017; 29: 134-135. https://doi.org/10.20882/adicciones.875
RICHARDS JR, LAPOINT JM, BURILLO-PUTZE G. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment. Clin Toxicol (Phila) 2017; 56: 15-24. https://doi.org/10.1080/15563650.2017.1349910
DEZIECK L, HAFEZ Z, CONICELLA A, BLOHM E, O'CONNOR MJ, SCHWARZ ES et al. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series. Clin Toxicol (Phila) 2017; 55: 908-913. https://doi.org/10.1080/15563650.2017.1324166
MILLER WE, SPIEKERMAN RE, HEPPER NG. Pneumomediastinum resulting from performing Valsalva maneuvers during marijuana smoking. Chest 1972; 62: 233. https://doi.org/10.1378/chest.62.2.233
PANACEK EA, SINGER AJ, SHERMAN BW, PRESCOTT A, RUTHERFORD WF. Spontaneous pneumomediastinum: clinical and natural history. Ann Emerg Med 1992; 21: 67-72. https://doi.org/10.1016/s0196-0644(05)81750-0
BRODY SL, ANDERSON JR GV, GUTMAN JB. Pneumomediastinum as a complication of ‘crack’ smoking. Am J Emerg Med 1988; 6: 241-243. https://doi.org/10.1016/0735-6757(88)90008-3
HERNÁNDEZ SÁNCHEZ MJ, BURILLO PUTZE G, ALONSO LASHERAS JE, CASAÑAS CULLEN JM ¿Cambios en la forma de presentación del neumomediastino espontáneo? Emergencias 1998; 10: 9-13.
LÓPEZ LÓPEZ L, RAMÍREZ BUENO A, KUBARSEPP A. Anisocoria como síntoma asociado a neumomediastino espontáneo. Arch Bronconeumol 2018; 54: 437-439. https://doi.org/10.1016/j.arbres.2017.10.019
FERNÁNDEZ-ATUTXA A, DE CASTRO L, ARÉVALO-SENRA JA, LANGARA E, CABRIADA-NUÑO JL. Cannabis intake and intussusception: an accidental association?. Rev Esp Enferm Dig 2017; 109: 157-159. https://doi.org/10.17235/reed.2016.4288/2016
BURILLO-PUTZE G, MATOS CASTRO S. Los servicios de urgencias como atalaya de los patrones de uso de drogas y sus consecuencias clínicas. Emergencias 2018; 30: 377-379. https://doi.org/10.2307/j.ctt1zgwktz.4
PINEDO-PAINOUS I, GARRIDO-ROMERO R, VALLS-LAFON A, MUÑOZ-SANTANACH D, MARTÍNEZ-SÁNCHEZ L. Intoxicación por cannabis en menores de 3 años. Emergencias 2018; 30: 408-411.
KIM HS, MONTE AA. Colorado cannabis legalization and its effect on emergency care. Ann Emerg Med 2016; 68: 71-75. https://doi.org/10.1016/j.annemergmed.2016.01.004
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.